NICE set to recommend Stelara for psoriasis
This article was originally published in Scrip
Executive Summary
The health technology assessment agency for England and Wales, NICE, has confirmed its view that Janssen-Cilag's (Johnson & Johnson) Stelara (ustekinumab) should be a treatment option for some patients with severe plaque psoriasis.